From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA Expands Indication for IN.PACT Admiral Balloon in PAD

from Medscape

The U.S, Food and Drug Administration has approved Medtronic's IN.PACT Admiral drug-coated balloon to treat long superficial femoral artery lesions up to 360 mm in patients with peripheral artery disease, the company announced. The approval is based on data from the complex lesion imaging cohorts of the IN.PACT Global Study, including long lesion, in-stent restenosis and chronic total occlusion groups with lesion lengths greater than 180 mm. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063